The histone demethylase KDM6B preserves adipogenic balance by restraining hypermetabolic LYVE1+ perivascular macrophages.
Aznar Bastien B, Mezdari Zaïneb Z, He Jialing J, Ballaire Raphaëlle R et al.
White adipose tissue expandability protects against metabolic disease, yet the epigenetic programmes that maintain the macrophage states supporting this adaptation remain poorly defined. Here we show that the H3K27 demethylase KDM6B sustains LYVE1+ adipose tissue perivascular macrophages (PVMs) during diet-induced white adipose tissue expansion, thereby maintaining adipogenic balance. In humans, KDM6B expression in adipose tissue macrophages associates with insulin sensitivity, glycaemic control and reduced inflammation. In mice, myeloid Kdm6b deletion reprogrammes septal and capsular LYVE1+ macrophages towards a CLEC1A+ hypermetabolic perivascular state, leading to defective adipogenesis, adipocyte hypertrophy, vascular rarefaction, inflammation and impaired glucose homeostasis. Mechanistically, KDM6B limits H3K27me3 deposition at the Bmp2 locus to maintain macrophage-derived BMP2 signalling to adipose progenitors. Myeloid Bmp2 deletion partially recapitulates Kdm6b-deficient adipose dysfunction, whereas recombinant BMP2 promotes homeostatic tissue remodelling. Collectively, KDM6B acts as an epigenetic switch controlling the metabolic fate of LYVE1+ PVMs, maintaining the balance between adipogenesis-supportive and metabolic PVM states that determine adipose tissue expandability and metabolic homeostasis.